Previous studies have shown that kaempferol can alleviate disease symptoms by inhibiting neutrophil infiltration or the activity of MPO in the high-fat-diet-induced obesity model [39], the lung I/R injury model [40], the keratitis model [41] and the gastric mucosal injury model [42]. This evidence concerns the gene MPO and obesity due to melanocortin 4 receptor deficiency.